文献速递创伤与烧伤重症综合管理与镇静镇痛

钝性脾创伤中更靶向的栓塞策略减少手术量而不增加脾切除率

A more targeted embolization strategy in blunt splenic trauma reduces procedural volume without increasing splenectomy rates.
PubMed 文献 · J Trauma Acute Care Surg · 2025-07-17
一句话结论对血流动力学稳定的钝性脾损伤患者,仅对高风险特征行脾动脉栓塞可减少栓塞使用而不增加总体或延迟脾切除率。

该研究回顾了840例血流动力学稳定、初始增强CT显示AAST II-V级钝性脾损伤的患者,排除CT前已行脾切除者。以2019年1月引入新算法为界,采用中断时间序列分析比较前3年与后5.5年的PRE组(369例)与POST组(471例)。新算法仅对高风险特征(假性动脉瘤≥10 mm、中大量腹腔积血、显著实质损伤)推荐强制脾动脉栓塞。结果显示脾动脉栓塞率从29%降至17%(p<0.001),总体脾切除率(PRE 30% vs POST 34%,p=0.14)和延迟脾切除率(PRE 1.9% vs POST 3.6%,p=0.14)无显著变化。作者认为更选择性的栓塞策略可减少手术量而不增加脾切除率,未来研究应评估保守性脾动脉栓塞方法并更好界定哪些高风险特征可被栓塞缓解。

要点

  • 血流动力学稳定的AAST II-V级钝性脾损伤患者中,引入仅对高风险特征行强制脾动脉栓塞的算法后,脾动脉栓塞率从29%降至17%(p<0.001)。
  • 脾动脉栓塞率下降的同时,总体脾切除率无显著变化(PRE 30% vs POST 34%,p=0.14)。
  • 延迟脾切除(入院>24小时)率无显著变化(PRE 1.9% vs POST 3.6%,p=0.14)。
  • PRE与POST期间AAST分级和假性动脉瘤发生率无显著变化,但算法引入后每月脾动脉栓塞率的拟合时间趋势显示急剧下降(p=0.04)。
  • 作者认为未来研究应评估保守性脾动脉栓塞方法,并更好界定哪些高风险特征可被脾动脉栓塞缓解。

适用人群与场景

  • 血流动力学稳定、初始增强CT显示AAST II至V级钝性脾损伤的患者。
  • 排除CT前已行脾切除的患者。

诊断标准与关键阈值

  • 当前钝性脾损伤算法推荐仅对高风险特征行强制脾动脉栓塞:假性动脉瘤≥10 mm、中大量腹腔积血、显著实质损伤。

处置流程与药物剂量

  • 对血流动力学稳定的AAST II-V级钝性脾损伤患者,按当前算法仅对高风险特征(假性动脉瘤≥10 mm、中大量腹腔积血、显著实质损伤)行强制脾动脉栓塞。

研究设计与关键结果

  • 研究类型为中断时间序列分析,纳入840例血流动力学稳定的AAST II-V级钝性脾损伤患者,PRE组369例 vs POST组471例。
  • 脾动脉栓塞总率从PRE 29%降至POST 17%(p<0.001)。
  • 总体脾切除率PRE 30% vs POST 34%(p=0.14),无显著变化。
  • 延迟脾切除(入院>24小时)率PRE 1.9% vs POST 3.6%(p=0.14),无显著变化。
  • PRE与POST期间AAST分级和假性动脉瘤发生率无显著变化,算法引入后每月脾动脉栓塞率的拟合时间趋势显示急剧下降(p=0.04)。

证据类型、等级与局限

  • 证据类型:治疗/护理管理,证据等级Level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对血流动力学稳定的AAST II-V级钝性脾损伤患者,采用仅对高风险特征(假性动脉瘤≥10 mm、中大量腹腔积血、显著实质损伤)行强制脾动脉栓塞的更选择性策略,可减少脾动脉栓塞手术量而不增加总体或延迟脾切除率。
  • 作者认为未来研究应评估保守性脾动脉栓塞方法,并更好界定哪些高风险特征可被脾动脉栓塞缓解。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The role of splenic angioembolization (SAE) in blunt splenic injury (BSI) has evolved. Revision of the American Association for the Surgery of Trauma (AAST) Splenic Organ Injury Scale BSI classification scheme and increased quality of computed tomography (CT) scans may now identify injuries that no longer benefit from SAE. Our current BSI algorithm recommends mandatory SAE only for high-risk features (pseudoaneurysms ≥10 mm, moderate to large hemoperitoneum, significant parenchymal injury). We hypothesized that this strategy reduced the use of SAE without increasing overall splenectomy or delayed splenectomy rates.

METHODS: We reviewed hemodynamically stable patients with AAST Grades II to V BSI on initial contrast CT scan. Patients who underwent splenectomy prior to CT were excluded. An interrupted time-series analysis was performed with a cutoff of January 2019, when the algorithm was introduced, spanning 3 years before and 5.5 years after (PRE vs. POST). The primary outcomes of interest were changes in rates of SAE, overall splenectomy, and delayed splenectomy >24 hours after admission across the two time periods.

RESULTS: A total of 840 patients met the inclusion criteria, 369 individuals in the PRE group versus 471 in the POST group. The overall rate of SAE decreased from 29% to 17% ( p < 0.001) after algorithm implementation without a significant change in rates of overall splenectomy (PRE 30% vs. POST 34%, p = 0.14) or delayed splenectomy (PRE 1.9% vs. POST 3.6%, p = 0.14). In the absence of any significant changes in AAST grade or rates of pseudoaneurysm in the PRE and POST periods, fitted time trends for monthly rates of SAE demonstrate a sharp decline after introduction of the algorithm ( p = 0.04).

CONCLUSION: A more selective approach to the use of angioembolization for BSI leads to a reduction in procedural volumes without increasing overall or delayed splenectomy rates. Future research should evaluate conservative approaches of SAE while better defining which high-risk features are mitigated by SAE.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Marsh AM, Dhillon NK, Kozar RA, et al. A more targeted embolization strategy in blunt splenic trauma reduces procedural volume without increasing splenectomy rates. J Trauma Acute Care Surg. 2025. PMID: 40671189. doi:10.1097/TA.0000000000004710

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。